Also called: GRF 1-29, GHRH 1-29
Sermorelin is a substance that tells your body to make more of its own growth hormone. Growth hormone is a natural body chemical that helps with healing, muscle, and energy. Some clinics offer peptides like this as part of their care plans. In theory, sermorelin works by gently nudging a gland in your neck, called the pituitary, to release more growth hormone.
This is different from taking growth hormone directly. The idea is that your body stays in charge of how much it makes. Clinics that use growth hormone peptides say this may support muscle growth, fat burning, and recovery, and that it may be safer than taking growth hormone itself. Here is the honest truth: the pages that were reviewed do not actually give clear facts about sermorelin.
They mostly talk about other peptides or weight loss medicines. So there is not much proven information here about how well sermorelin works in real people. Anyone thinking about trying it should talk to a real doctor first, get blood tests, and be careful, because the science is not strong and rules about these products can be unclear.
Benefits
The main themes across 47 research studies, in plain language.
Studies indicate potential increases in lean muscle mass, muscle strength, and overall tone, alongside reductions in body fat, particularly in the abdominal area.
Findings imply that stimulating natural growth factors may help maintain or improve bone mineral density, potentially reducing the risk of osteoporosis.
Clinical research supports the use of the compound for increasing growth velocity in children with specific hormone deficiencies.
Research suggests that the compound stimulates the pituitary gland to release the body's own growth hormone and IGF-1, often preserving natural rhythmic pulses rather than causing a constant flood.
Research confirms the compound's utility as a diagnostic agent to provoke the pituitary gland and assess growth hormone reserve or deficiency.
Research indicates that combining this agent with other peptides (like GHRPs) can trigger a significantly stronger release of growth hormones than using them alone.
Some studies, particularly in men, suggest an improvement in libido and general well-being as part of hormonal optimization.
Research suggests that stimulating natural release may preserve the body's feedback mechanisms, potentially lowering risks associated with synthetic hormone overdosing.
Evidence suggests the compound may accelerate the repair of tissues, including muscles and joints, and aid recovery from physical training or injury.
Some research points to a reduction in systemic inflammation, which may contribute to recovery and neuroprotection.
Preliminary research suggests the therapy may support immune health by stimulating the production of immune cells like T-cells and regulating system responses.
Mechanistic studies suggest the compound may help reduce excessive tissue fibrosis or scarring.
Some studies indicate that the therapy may help regulate blood sugar and improve insulin sensitivity, potentially supporting metabolic health.
Animal and mechanistic studies indicate potential protective effects on heart tissue, such as reducing scarring after damage.
Research suggests potential benefits for mental clarity, memory, and focus, possibly linked to improved oxygen delivery or neuroprotective hormone activity.
Studies suggest that restoring hormone levels to more youthful ranges may support general vitality, longevity, and healthy aging.
Evidence suggests that increased hormone levels may support skin elasticity, hydration, and thickness, as well as overall connective tissue health.
Research points to improvements in sleep quality, specifically enhancing deep (slow-wave) sleep cycles and nocturnal hormone release, which may aid physical and mental recovery.
Laboratory research suggests the compound may inhibit the growth of specific tumor cells, such as gliomas, though this is an emerging area of study.
User-reported outcomes and some studies suggest improvements in overall energy, stamina, and mood, potentially related to better sleep and metabolic function.
You just read the research on Sermorelin. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Sermorelin is a synthetic analog of growth hormone releasing hormone comprising the biologically active N-terminal 1-29 fragment of GHRH. It stimulates the pituitary to release endogenous GH and is FDA-approved as a provocative (stimulation) diagnostic test for growth hormone deficiency, principally in children.
Evidence
Every claim above traces back to a source you can check — here are 10 of them.
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.
Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
PubChem - Compound - Sermorelin
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency
Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man
The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature
Sermorelin - MeSH
Timeline
Key moments in Sermorelin’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Sermorelin.
A November 2025 New York Times explainer takes a skeptical consumer lens to the peptide-therapy craze, separating the few uses with reasonable evidence (topical GHK-Cu and Matrixyl-type peptides in skincare) from the largely unproven injectable and "biohacking" market (BPC-157, TB-500, epitalon, semax, selank). Dermatologists frame cosmetic peptides as "sidekicks, not hero ingredients," while endocrinologists warn that growth-hormone-releasing peptides like sermorelin and tesamorelin carry the same long-term risks as HGH — diabetes, certain cancers, and acromegaly. The piece notes that most longevity claims rest on cell-culture or animal data only, and that "research-grade" products have no quality controls.
FDA's Dallas district office inspected Revive Rx LLC (Houston, TX) between January 27 and February 7, 2025 and issued a Form 483 citing sterile-failure observations — products exposed to sub-ISO 5 air and microbial contamination (mold and spore-forming bacteria) in production areas. The 483's product list includes Hexarelin 6 mg per Vial for Injection among the drugs the compounding pharmacy produced, alongside sermorelin and tesamorelin. The document is inspectional observations, not a final agency determination.
Wondering how Sermorelin pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
Related peptides
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.